Discover trends, market shifts, and competitive outlooks for the intussusception industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

How Has the Intussusception Market Growth Performance Trended Historically, And What Lies Ahead?

The market size for intussusception has seen robust growth in the past few years. The market is projected to expand from $4.45 billion in 2024 to $4.69 billion in 2025, representing a compound annual growth rate (CAGR) of 5.3%. The historic period’s growth is attributed to advancements in diagnostic methodologies, heightened awareness and education, worldwide growth of healthcare infrastructure, investment in research and development, and cooperation among healthcare bodies.

The market size for intussusception is projected to experience consistent growth in the upcoming years, with its value set to reach $5.52 billion by 2029, exhibiting a CAGR of 4.1%. This growth throughout the anticipated period is likely to stem from constant educational efforts in the medical field, programs aimed at vaccination for children, global endeavors enhancing pediatric healthcare, the priority given to postoperative care, the growing need for research focusing on pediatric gastrointestinal problems, and the accessibility of telemedicine and remote healthcare services. Noteworthy trends throughout this period incorporate progress in diagnostic imaging, advents in minimally invasive treatment modes, the design of child-specific interventions, studies aiming on etiology and risk factors, extensive epidemiological investigations, implementation of vaccination programs, and the usage of telemedicine for diagnoses and consultations.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13466&type=smp

Which Major Market Drivers Are Expected to Boost the Growth Potential of the Intussusception Market?

The escalating occurrences of intestinal disorders are poised to contribute significantly to the growth trajectory of the intussusception market. Intestinal disorders encompass a range of medical complications and health issues that impede the optimal function of the intestines, organs pivotal to nutrient absorption and waste disposal. The upward trend of intestinal disorders like inflammatory bowel disease and gastrointestinal cancers enables earlier detection, superior treatment alternatives, and reinforced support for those affected by intussusception, ultimately enriching their health and lifestyle. Illustratively, the American Cancer Society (ACS), a health institution in the US with a mission to eradicate cancer, reported in January 2023 that gastrointestinal cancers had risen by 3.18% to 348,840 from 338,090 in 2021 within the US. Consequently, the surge in intestinal disorders will catalyze the expansion of the intussusception market.

Intussusception Market Driver: Augmented Intussusception Market Spurred By Mounting Health Care Expenditure

Which Key Market Segments Comprise the Intussusception Market and Drive Its Revenue Growth?

The intussusception market covered in this report is segmented –

1) By Type: Idiopathic Intussusception, Secondary Intussusception

2) By Treatment: Enema Reduction, Surgery, Other Treatment

3) By Diagnosis: Barium Enema, Ultrasound, X-Ray, Computerized Tomography (CT)

4) By End-User: Hospitals, Clinics, Other End-User

Subsegments:

1) By Idiopathic Intussusception: Childhood Idiopathic Intussusception, Adult Idiopathic Intussusception

2) By Secondary Intussusception: Neoplastic Intussusception, Infectious Intussusception, Inflammatory Intussusception, Post-Surgical Intussusception

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=13466&type=smp

Which Areas Are Leading Regions in the Intussusception Market Expansion Across the Globe?

North America was the largest region in the intussusception market in 2024. The regions covered in the intussusception market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Key Market Trends in theIntussusception Market Over the Coming Years?

Leading companies in the market for treating intestinal pseudo-obstruction are innovating with new drug therapies such as NHE3 inhibitor treatment therapy, aiming to offer credible services to their clients. The NHE3 inhibitor treatment therapy is a medication that functions by disrupting the Sodium-Proton-Exchanger subtype 3 (NHE3) in the intestines. Ardelyx Inc., a biopharmaceutical firm from the US, debuted its NHE3 inhibitor treatment known as IBSRELA for adults suffering from irritable bowel syndrome with constipation (IBS-C) in April 2022. This potentially enhances gastrointestinal mobility. The way IBSRELA operates is by halting or obstructing the Sodium-Hydrogen Exchanger 3 (NHE3) protein’s activity. The authorization of IBSRELA stems from two Phase 3 studies that involved over 1,200 IBS-C patients. The drug proved to significantly alleviate abdominal discomfort and enhance bowel movements, accomplishing the primary endpoint. Patients reported improvements as early as Week 1, which sustained over 26 weeks in the long-term trial.

View the full report here:

https://www.thebusinessresearchcompany.com/report/intussusception-global-market-report

How Is the Intussusception Market Conceptually Defined?

Intussusception is a medical condition in which one portion of the intestine slides into an adjacent section of the intestine, blocking the flow of food, fluids, and gas through the affected part of the intestine, leading to symptoms such as severe abdominal pain, vomiting, and bloody stools. It is usually diagnosed based on the symptoms, physical examination, and imaging tests.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13466

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model